Image

Study of VYD2311 for the Prevention of COVID-19

Testing VYD2311 to help prevent COVID-19 infection.

Recruiting
12 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study of VYD2311 for the Prevention of COVID-19: This study tests a new medicine called VYD2311, which is a monoclonal antibody. A monoclonal antibody is a special protein that can attach to viruses and help stop them from entering your cells. This study is for people aged 12 and up. Participants will receive either VYD2311 or a placebo, which is a harmless substance that looks like the medicine but has no effect. The medicine or placebo is given as a shot in the upper thigh or arm once a month, totaling three shots.

The study lasts 90 days from the first shot and checks how well VYD2311 works to prevent COVID-19. It also looks at the safety of the medicine, how the body processes it, and how it helps the immune system fight the virus. Blood tests will be done during the study to gather this information.

  • The study involves three visits for shots, one each month.
  • Participants should be able to receive study reminders on a device like a phone.
  • Participants must not have had COVID-19 or related treatments recently.
Print
Study details
    COVID-19

NCT07298434

Invivyd, Inc.

14 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.